Special Issue "Clinical Advances of Human Papillomaviruses"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383).
Deadline for manuscript submissions: closed (30 September 2014)
Prof. Dr. Stephen K. Tyring (Website)
The University of Texas, Medical School at Houston, 1401 Binz, Suite 200, Houston, TX 77004, USA
Fax: +713 524 3432
Interests: cutaneous infectious diseases; cutaneous immunology; cutaneous oncology
Dr. Christopher Downing (Website)
Center for Clinical Studies, 1401 Binz Ave, Suite 200, Houston, TX 77004, USA
Fax: +281 335 4605
Interests: psoriasis; atopic dermatitis; HPV; HSV; postherpetic neuralgia
Dr. Jacqueline Guidry (Website)
Center for Clinical Studies, 1401 Binz Ave, Suite 200, Houston, TX 77004 USA
Phone: +713 528 8818
Fax: +713 528 8848
Interests: psoriasis; HPV; HSV; atopic dermatitis; acne
The human papillomavirus (HPV) is responsible for the majority of newly acquired sexually transmitted infections (STIs) in the United States (in the year 2013). HPV is also an essential carcinogen; it is increasingly implicated in association with cancers occurring at numerous sites of the body, including the oropharynx. The virus is well-known as the cause of nearly 100 percent of all cervical cancers. The significant health and economic burdens of disease continue to stimulate research on the virus, with special interest in decreasing disease transmissibility through vaccination and improvements in cancer screening. Recent screening advancements by national health organizations have guided physicians in the way they screen for cervical cancer with respect to starting and stopping age, frequency, and select groups for which the standard recommendations do not apply. Although there is not currently any specific treatment for the HPV infection, the diseases it causes are treatable. Two vaccines have been developed against HPV infection: the bivalent and quadrivalent vaccines approved in 2006 for use in women and the quadrivalent vaccine approved in 2009 for use in men (as well as women).
This Special Issue is composed of articles that reflect the latest developments of the human papillomaviruses, with additional focus on anticipated advances of the disease.
Prof. Dr. Stephen Tyring
Dr. Christopher Downing
Dr. Jacqueline Guidry
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed Open Access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 300 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- cervical cancer
- pap smear